## Abstract ## Objectives/Hypothesis: Assess for complications of intranasal Bevacizumab application in patients with hereditary hemorrhagic telangiectasia (HHT)‐associated epistaxis. ## Study Design: Retrospective chart review. ## Methods: In 58 patients presenting with recurrent HHT epistaxi
Efficiency of laser treatment in patients with hereditary hemorrhagic telangiectasia
✍ Scribed by Gita Jørgensen; Bibi Lange; Jens Højberg Wanscher; Anette Drøhse Kjeldsen
- Publisher
- Springer-Verlag
- Year
- 2011
- Tongue
- English
- Weight
- 300 KB
- Volume
- 268
- Category
- Article
- ISSN
- 0302-9530
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objectives/ Hypothesis: Intranasal Bevacizumab is an effective therapy for epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT). ## Study Design: Retrospective chart review. ## Methods: In 32 successive patients presenting with recurrent HHT epistaxis 25–100 mg
Liver involvement in hereditary hemorrhagic telangiectasia may lead to high-output cardiac failure. Few data have been reported on orthotopic liver transplantation (OLT) for these patients. In this paper, we describe two patients treated by OLT as a salvage procedure for cardiac failure, and we revi